Key result
A 53-year-old Brazilian woman living in Europe was diagnosed with Chagas cardiomyopathy and treated with nifurtimox, highlighting the need for high clinical suspicion in non-endemic countries.
Case Report (n=1)
Highlights the importance of recognizing Chagas cardiomyopathy in non-endemic countries due to emigration, emphasizing the need for high clinical suspicion and screening in high-risk groups.
May warrant consideration of Chagas cardiomyopathy in at-risk migrants in Europe; leaves open the value of systematic screening.
Due to recent population emigration movements, an epidemic of Chagas disease is currently menacing most developed countries. The authors report the case of a 53-year-old Brazilian woman living in Europe for the last 10 years who developed heart failure symptoms, having a previous symptomatic sinus node disease with a pacemaker implant at age of 40 years. The diagnosis was based on serology and myocardial biopsy and the patient was treated with nifurtimox. The authors emphasize the need of a high level of suspicion in patients with suggestive epidemiology and the need of populational screening of specific high risk groups. New treatment options are also discussed.
No takes yet. Share an insight, caveat, or question.
Joana Cortez (2012) conducted a case report in Chagas cardiomyopathy (n=1). Nifurtimox was evaluated. A 53-year-old Brazilian woman living in Europe was diagnosed with Chagas cardiomyopathy and treated with nifurtimox, highlighting the need for high clinical suspicion in non-endemic countries.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: